Complement-mediated solubilization of immune complexes in systemic lupus erythematosus
- PMID: 6979449
- PMCID: PMC1536587
Complement-mediated solubilization of immune complexes in systemic lupus erythematosus
Abstract
The capacity of complement-mediated solubilization of immune complexes (complex releasing activity: CRA) was studied in 63 sera from eight systemic lupus erythematosus (SLE) patients. CRA in sera of active SLE (35 +/- 17.%) was significantly lower than that of inactive SLE (64.1 +/- 24.1%, P less than 0.001). In addition, 20 of 23 sera collected during active diseases demonstrated CRA values less than 50% of the control pooled serum. On the other hand, CRA of 29 of 40 sera from inactive disease exceeded the 50% level. CRA in SLE sera correlated with complement component levels and in particular with the CH50. Serial determination of CRA and of levels of circulating immune complexes (CIC), C4 and C3 in two active patients indicated that the correlation between CRA and the complement components was positive, while that between CRA and CIC was negative. These studies provide evidence that CRA may be useful for following the activity of SLE and that CRA reflects the levels of the complement components of both classical and alternative pathways. The possibility that CIC may be solubilized and opsonized by complement and cleared by the reticuloendothelial system was discussed.
Similar articles
-
Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.Clin Exp Immunol. 1984 Mar;55(3):487-94. Clin Exp Immunol. 1984. PMID: 6608422 Free PMC article.
-
[Serum complement levels in patients with rheumatoid arthritis and vasculitis].Fukuoka Igaku Zasshi. 1989 Oct;80(10):456-66. Fukuoka Igaku Zasshi. 1989. PMID: 2613159 Japanese.
-
Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.J Clin Lab Immunol. 1988 Jun;26(2):73-9. J Clin Lab Immunol. 1988. PMID: 3264027
-
[Is the demonstration of immune complex useful in the activity assessment of chronic polyarthritis?].Schweiz Med Wochenschr. 1984 Jan 28;114(4):118-30. Schweiz Med Wochenschr. 1984. PMID: 6367028 Review. German.
-
Complement deficiencies and systemic lupus erythematosus.Autoimmunity. 2007 Dec;40(8):560-6. doi: 10.1080/08916930701510673. Autoimmunity. 2007. PMID: 18075790 Review.
Cited by
-
Formation of soluble immune complexes by complement in sera of patients with various hypocomplementemic states. Difference between inhibition of immune precipitation and solubilization.J Clin Invest. 1985 Dec;76(6):2127-33. doi: 10.1172/JCI112217. J Clin Invest. 1985. PMID: 2934406 Free PMC article.
-
Factors influencing immune complex localisation.Rheumatol Int. 1984;4(3):95-109. doi: 10.1007/BF00541177. Rheumatol Int. 1984. PMID: 6235569 Review.
-
Synergistic Activation of Toll-Like and NOD Receptors by Complementary Antigens as Facilitators of Autoimmune Disease: Review, Model and Novel Predictions.Int J Mol Sci. 2020 Jun 30;21(13):4645. doi: 10.3390/ijms21134645. Int J Mol Sci. 2020. PMID: 32629865 Free PMC article. Review.
-
Solubilization of intraglomerular deposits of IgG immune complexes by human sera or gamma-globulin in patients with lupus nephritis.Clin Exp Immunol. 1984 Oct;58(1):42-8. Clin Exp Immunol. 1984. PMID: 6206971 Free PMC article.
-
Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera.Clin Exp Immunol. 1983 Nov;54(2):439-47. Clin Exp Immunol. 1983. PMID: 6652967 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous